Alle subsidies

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)

SACCCT – Projetos de Ciência de Contexto Europeu

Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

Regione Valle d'Aosta - Avviso per la concessione di incentivi alle imprese per l’inserimento di persone con disabilità - Anno 2026-2027

PASS Transitions

Subvention Prévention TPE - Réduction de l'exposition au gaz radon

WIPANO – Wissens- und Technologietransfer durch Patente und Normen

Contributo a fondo perduto per l’indennizzo dei danni materiali diretti subiti dalle imprese esportatrici dei territori delle province di Firenze, Livorno, Pisa, Pistoia e Prato in seguito agli eventi alluvionali verificatisi a partire dal 2 novembre 2023

Trusted, secure, quality future digital travel credentials

Detection and characterisation of threats or illegal/ smuggled goods in cargo

Open Topic on advanced protective gear optimized for CBRN-E (Chemical, Biological, Radiological, Nuclear, Explosives) environments and new generation of smart protective equipment for disaster responders

Enhancing decision support system for disaster crises: leveraging emerging technologies for improved civil preparedness and crisis management

Community policing in diverse societies in Europe

Impact of malicious use of Open-Source Intelligence on critical infrastructure business continuity

Open grounds for future pre-commercial procurement of innovative security technologies

Appel à projets Horizon Europe - 2ème pilier : Problématiques mondiales et compétitivité industrielle européenne - cluster sécurité

Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)